25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma.

[1]  W. Xu,et al.  The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma , 2020, Annals of Hematology.

[2]  W. Xu,et al.  Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma , 2020, Annals of Hematology.

[3]  W. Xu,et al.  25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma , 2020, Journal of Cancer Research and Clinical Oncology.

[4]  R. Ullrich,et al.  Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Yun-Chul Hong,et al.  Vitamin D status and risk of non-Hodgkin lymphoma: An updated meta-analysis , 2019, PLoS ONE.

[6]  J. Meyerhardt,et al.  Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial , 2019, JAMA.

[7]  B. Zhang,et al.  Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin’s lymphoma, in vitro , 2019, BMC Research Notes.

[8]  E. Guallar,et al.  Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T‐cell lymphoma , 2018, Cancer science.

[9]  M. Federico,et al.  Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018 .

[10]  J. Pérez-Simón,et al.  Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications , 2018, International journal of molecular sciences.

[11]  L. Larocca,et al.  Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy , 2017, Cancer medicine.

[12]  John H. White,et al.  Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice , 2017, The Journal of Biological Chemistry.

[13]  Michael F. Holick,et al.  The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention , 2017, Reviews in Endocrine and Metabolic Disorders.

[14]  T. Loughran,et al.  Vitamin D in hematological disorders and malignancies , 2017, European journal of haematology.

[15]  J. Cerhan,et al.  Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma , 2017, Blood Cancer Journal.

[16]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[17]  M. Ziepert,et al.  Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Maïga,et al.  Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK , 2014, Cell Death and Disease.

[19]  D. Steinhilber,et al.  Vitamin D in inflammatory diseases , 2014, Front. Physiol..

[20]  Jing-quan Li,et al.  Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.

[21]  M. Hansmann,et al.  Vitamin D3 receptor is highly expressed in Hodgkin’s lymphoma , 2012, BMC Cancer.

[22]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[23]  J. Cerhan,et al.  Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Peizhan Chen,et al.  Meta-analysis of vitamin D, calcium and the prevention of breast cancer , 2010, Breast Cancer Research and Treatment.

[25]  John H. White,et al.  Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease* , 2009, The Journal of Biological Chemistry.

[26]  V. Arndt,et al.  Meta‐analysis: longitudinal studies of serum vitamin D and colorectal cancer risk , 2009, Alimentary pharmacology & therapeutics.

[27]  S. Cremers,et al.  High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Edward Giovannucci,et al.  Vitamin D and prevention of colorectal cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  N. Bundred,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo , 2000 .

[30]  J. Cerhan,et al.  Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. , 2011, Blood.

[31]  D. Bikle.  Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.